[1]
|
Navab, M., Berliner, J.A., Watson, A.D., Hama, S.Y., Territo, M.C., Lusis, A.J., Shih, D.M,, Van Lenten, B.J., Frank, J.S., Demer, L.L., Edwards, P.A. and Fogelman, A.M. (1996) The Yin and Yang of oxidation in the de- velopment of the fatty streak. A review based on the 1994 George Lyman Duff Me-morial Lecture. Arterioscler Thrombosis and Vascular Biology, 16, 831-842.
doi:10.1161/01.ATV.16.7.831
|
[2]
|
Stamler, J., Vaccaro, O., Neaton, J.D. and Wentworth, D. (1993) The Multiple Risk Fac-tor Intervention Trial Re- search Group. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 16, 434- 444. doi:10.2337/diacare.16.2.434
|
[3]
|
Tas, S. (1991) Genetic predisposition to coronary heart disease and gene for apolipoprotein-CIII. Lancet, 337, 113-114. doi:10.1016/0140-6736(91)90770-P
|
[4]
|
Ukkola, O., Savolai-nen, M.J., Salmela, P.I., von-Dickhoff, K. and Kesaniemi, Y.A. (1995) DNA poly-morphisms at the lipoprotein lipase gene are as-sociated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus. Atherosclerosis, 115, 99-105.
doi:10.1016/0021-9150(94)05504-C
|
[5]
|
Steinberg, D. and Witzum, J.L. (1990) Lipoproteins and atherogenesis. The Journal of American Medical Associ- ation, 264, 3047-3052.
doi:10.1001/jama.1990.03450230083034
|
[6]
|
Mackness, M.I., Arrol, S., Abbott, C. and Durrington, P.N. (1993) Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associa- ted paraoxonase. Atheroscle-rosis, 104, 129-135.
doi:10.1016/0021-9150(93)90183-U
|
[7]
|
Mackness, M.I., Mackness, B., Durrington, P.N., Connelly, P.W. and Hegele, R.A. (1996) Paraoxonase: Bio- chemistry, genetics and rela-tionship to plasma lipoproteins. Current Opinion in Lipidology, 7, 69-76.
doi:10.1097/00041433-199604000-00004
|
[8]
|
Humbert, R, Adler, D.A., Disteche, C.M., Hassett, C., Omiecinski, C.J. and Furlong, C.E. (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nature Genetics, 3, 73-76. doi:10.1038/ng0193-73
|
[9]
|
Hassett, C., Richter, R.J., Humbert, R., Chapline, C., Crabb, J.W., Omiecinski, C.J. and Furlong, C.E. (1991) Characterization of cDNA clones encoding rabbit and human serum paraoxonase: The mature protein retains its sig- nal sequence. Biochemistry, 30, 10141-10149.
doi:10.1021/bi00106a010
|
[10]
|
Pfohl, M., Koch, M., Enderle, M., Kühn, R., Füllhase, J., Karsch, K. and H?ring, H. (1999) Paraoxonase 192 Gln/ Arg gene polymorphism, coronary artery disease, and myo- cardial infarction in type 2 diabetes. Diabetes, 48, 623- 627. doi:10.2337/diabetes.48.3.623
|
[11]
|
Odawara, M., Tachi, Y. and Yamashita, K. (1997) Para- oxonase polymor-phism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsul-independent diabetes mellitus. Journal of Clinical Endocrinology Metabolism, 82, 2257-2260. doi:10.1210/jc.82.7.2257
|
[12]
|
Serrato, M. and Marian, A.J. (1995) A variant of human paraoxonase/arylesterase (HUM-PONA) gene is a risk fac- tor for coronary artery disease. Journal of Clinical Investion, 96, 3005-3008. doi:10.1172/JCI118373
|
[13]
|
Antikainen, M., Murtomaki, S., Syvanne, M., Pahlman, R., Tahvanainen, E., Jauhiainen, M., Frick and M.H., Ehnholm, C. (1996) The Gln-Arg191 poly-morphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. Journal of Clinical Investigation, 98, 883-885.
doi:10.1172/JCI118869
|
[14]
|
Suehiro, T., Nakauchi, Y., Ya-mamoto, M., Arii, K., Itoh, H., Hamashige, N. and Hashimoto, K. (1996) Paraoxo- nase gene polymorphism in Japanese sub-jects with coro- nary heart disease. International Journal of Cardiovascular, 57, 69-73. doi:10.1016/S0167-5273(96)02779-9
|
[15]
|
Sanghera, D.K., Saha, N., Aston, C.E. and Kamboh, M.I. (1997) Genetic poly-morphism of paraoxonase and the risk of coronary heart disease. Arterioscler Thrombosis and Vascular Biology, 17, 1067-1073.
doi:10.1161/01.ATV.17.6.1067
|
[16]
|
WHO Consultation. De-finition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Report No 99.2. World Health Organization, Geneva, 1999.
|
[17]
|
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997). Diabetes Care, 20, 1183-1197.
|
[18]
|
American Diabetes Association (2005) Diagnosis and cla- ssification of diabetes mellitus. Diabetes Care, 28, S37- S42. doi:10.2337/diacare.28.suppl_1.S37
|
[19]
|
Schiller, N.B., Shah, P.M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D. and Schnittger, I. (1989) Recommendations for quantitation of the left ventricle by 2-dimensional echo- cardiography. Journal of American Society Echocardiography, 2, 358-367.
|
[20]
|
Yvorchuk, K.J., Davies, R.A. and Chang, K.L. (1994) Measurement of left ventricular ejection fraction by acou- stic quantification and comparison with radionuclide angiography. American Journal of Cardiology, 74, 1052- 1056. doi:10.1016/0002-9149(94)90858-3
|
[21]
|
Reiber, J.H., Serruys, P.W., Kooijman, C.J., Wijns, W., Slager, C.J., Gerbrands, J.J., Schuurbiers, J.C., den Boer, A. and Hugenholtz, P.G. (1985) Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation, 71, 280-288.
doi:10.1161/01.CIR.71.2.280
|
[22]
|
Murk, M. (2007) Levinson: Leaning center for coronary angiography. The heart surgery forum. Cardio-Thoracic Multimedia Journal, 54, 534-539.
doi:10.2337/diabetes.54.2.534
|
[23]
|
Schulze, M.B., Shai, I. and Rimm, E.B. (2005) Adipo- nectin and future coronary heart disease events among men with type 2 diabetes. Diabetes, 54, 534-539.
|
[24]
|
Wolk, R., Berger, P., Lennon, R.J., Brilakis, E.S. and Somers, V.K. (2003) Body mass index: A risk factor for unstable angina and myocardial infarction in patients with an-giographically confirmed coronary artery disease. Circulation, 108, 2206-2211.
|
[25]
|
Friedewald, W.T., Levy, R.I. and Fre-drickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemical, 18, 499-502.
|
[26]
|
Miller, S.A., Dykes, D.D. and Polesky, H.F. (1989) A simple salt-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215.
doi:10.1093/nar/16.3.1215
|
[27]
|
Adkin, S., Gan, K.N., Mody, M. and La Du, B.N. (1993) Molecular basis for the polymorphic forms of human serum paraoinase/arylesterase: Glutamine or arginin at position 192, for the respective A or B allozymes. American Journal of Human Genetics, 52, 598-608.
|
[28]
|
Saunders, B.D. and Trapp, R.G. (1994) Basic and clinical biostatistics. 1994. 2nd Edition, Appleton & Lange, Norwalk.
|
[29]
|
Maritim, A.C., Sanders, R.A. and Watkins, J.B. (2003) Diabetes, oxidative stress, and antioxidants: A review. Journal of Biochemical Toxicology, 17, 24-38.
doi:10.1002/jbt.10058
|
[30]
|
Flekac, M., ?krha, J., Zidkova, K., Lacinova, Z., Hilgertova, J. (2008) Paraoxonase 1 Gene poly-mor-phisms and enzyme activities in diabetes mellitus. Physio-logical Research, 57, 717-726.
|
[31]
|
Ruiz, J., Blanche, H., James, R.W., Garin, M.C., Vaisse, C., Charpentier, G., Cohen, N., Morabia, A., Passa and P., Froguel, P. (1995) Gln-Arg192 polymorphism of parao- xonase and coronary heart disease in type 2 diabetes. Lancet, 346, 869-872.
doi:10.1016/S0140-6736(95)92709-3
|
[32]
|
Jalilian, A., Javadi, E., Doosti, M., Amiri, P., Mohaghegh, A. and Shariati, B. (2008) Association between the severity of angiographic coronary artery disease and parao- xonase 1 promoter gene polymorphism T (–107) in iranian population. Acta Medica Iranica, 46, 197-202.
|
[33]
|
James, R.W., Leviev, I., Ruiz, J., Passa, P., Froguel, P. and Garin, M.C. (2000) Promoter polymorphism T(–107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients. Diabetes, 49, 1390- 1393. doi:10.2337/diabetes.49.8.1390
|
[34]
|
Lavi, S., Mcconnell, J., Lavi, R., Barsness, G., Rihal, C., Novak, G., Lerman, L. and Lerman, A. (2008) Association between the paraoxonase-1 192Q > R allelic variant and coronary endothelial dysfunction in patients with early coronary artery disease. Mayo Clinical Proceeding, 83, 158-164. doi:10.4065/83.2.158
|
[35]
|
Schwartz, C.J., Valente, A.J., Sprague, E.A., Kelley, J.L., Cayatte, A.J. and Rozek, M.M. (1992) Pathogenesis of the atherosclerotic lesion: Implications for diabetes mellitus. Circulation, 15, 1156-1167.
|
[36]
|
Lyons, T.J., Li, W., Wells-Knecht, M.C. and Jokl, R. (1994) Toxicity of mildly modified low density lipopro- teins to cultured retinal capillary endothelial cells and pe- ricytes. Diabetes, 43, 1090-1095.
doi:10.2337/diabetes.43.9.1090
|
[37]
|
Watanabe, J., Wohltmann, H.J., Klein, R.L., Colwell, J.A. and Lopes-Virella, M.F. (1988) Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients. Diabetes, 37, 1652-1657.
doi:10.2337/diabetes.37.12.1652
|
[38]
|
Kobayashi, K., Watanabe, J., Umeda, F. and Nawata, H. (1995) Glycation accelerates the oxidation of low density lipoprotein by copper ions. Endocrine Journal, 42, 461- 465. doi:10.1507/endocrj.42.461
|
[39]
|
Church, D.F. and Pryor, W.A. (1985) The free radical chemistry of cigarette smoke and toxicological impli- cations. Environmental Health Perspectives, 64, 111-126.
|
[40]
|
Chow, C.K., Thacker, R.R., Changcit, C., Bridges, R.B., Rehm, S.R., Humble, J. and Turbe, K.J. (1986) Lower levels of vitamin C and carotenes in plasma of cigarette smokers. Journal of the American College Nutrition, 5, 305-312.
|
[41]
|
Princen, H.M.G., van Poppel, G., Vogelezang, C., Buytenhek, R. and Kok, F.J. (1992) Supplementation with vitamin E but not b-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro: Effect of cigarette smoking. Arteriosclerosis Thrombosis, 12, 554-562.
doi:10.1161/01.ATV.12.5.554
|
[42]
|
Scheffler, E., Wiest, E., Woehrle, J., Otto, I., Schulz, I., Huber, L., Ziegler, R. and Dresel, H.A. (1992) Smoking influences the atherogenic potential of low-density lipoprotein. Clinical & Investigative Medicine, 70, 263-268.
|
[43]
|
Nishio, E. and Watanabe, Y. (1997) Cigarette smoke ex- tract inhibits plasma paraoxonase activity by modification of the enzyme’s free thiols. Biochemical and Bi-ophysical Research Communications, 236, 289-293.
|
[44]
|
Efrat, M. and Aviram, M. (2010) Paraoxonase 1 interactions with HDL, antioxidants and macrophages regulate atherogenesis—A protective role for HDL phospholipids. Advances in Experi-mental Medicine and Biology, 660, 153-166. doi:10.1007/978-1-60761-350-3_14
|
[45]
|
Barter, P. (2005) The role of HDL-cholesterol in preven- ting atherosclerotic disease. European Heart Journal, 7, F4-F8. doi:10.1093/eurheartj/sui036
|